Cystatin-B is expressed by neural stem cells and by differentiated neurons and astrocytes

Biochemical and Biophysical Research Communications

Volumn 308, Issue 2, 2003, Pages 369-374

  Brännvall, Karin ^a   Hjelm, Helena ^a   Korhonen, Laura ^a   Lahtinen, Ulla ^b   Lehesjoki, Anna Elina ^b   Lindholm, Dan ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

Author keywords

Cystatin B; Differentiation; Epilepsy; Immunohistochemistry; Lysosomes; Nerve cells; Neural stem cells

Indexed keywords

CYSTATIN B;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CELL; CELL MATURATION; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; EMBRYO; GLIA CELL; IMMUNOHISTOCHEMISTRY; LYSOSOME; NERVE CELL DIFFERENTIATION; NEUROBLAST; NEUROEPITHELIUM; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; STEM CELL;

EID: 0041592525     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01386-X     Document Type: Article

References (23)

1. Koskiniemi M., Donner M., Majuri H., Haltia M., Norio R. Progressive myoclonus epilepsy. A clinical and histopathological study. Acta Neurol. Scand. 50:1974;307-332.
2. Norio R., Koskiniemi M. Progressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finnish patients. Clin. Genet. 15:1979;382-398.
3. Eldridge R., Iivanainen M., Stern R., Koerber T., Wilder B.J. 'Baltic' myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet. 2:1983;838-842.
4. Haltia M., Kristensson K., Sourander P. Neuropathological studies in three Scandinavian cases of progressive myoclonus epilepsy. Acta Neurol. Scand. 45:1969;63-77.
5. Genton P., Michelucci R., Tassinari C.A., Roger J. The Ramsay Hunt syndrome revisited: mediterranean myoclonus versus mitochondrial encephalomyopathy with ragged-red fibers and baltic myoclonus. Acta Neurol. Scand. 81:1990;8-15.
6. Pennacchio L.A., Lehesjoki A.-E., Stone N.E., Willour V.L., Virtaneva K., Miao J., D'Amato E., Ramirez L., Faham M., Koskiniemi M., Warrington J., Norio R., de la Chapelle A., Cox D.R., Myers R.M. Mutations in the gene encoding cystatin B cause progressive myoclonus epilepsy (EPM1). Science. 271:1996;1731-1734.
7. Virtaneva K., D'Amato E., Miao J., Koskiniemi M., Norio R., Avanzini G., Franceschetti S., Michelucci R., Tassinari C.A., Omer S., Pennacchio L.A., Myers R.M., Dieguez-Lucena J.L., Krahe R., de la Chapelle A., Lehesjoki A.-E. Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat. Genet. 15:1997;393-396.
8. Lalioti M.D., Scott H.S., Buresi C., Rossier C., Bottani A., Morris M.A., Malafosse A., Antonarakis S.E. Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature. 386:1997;847-851.
9. Alakurtti K., Virtaneva K., Joensuu T., Palvimo J.J., Lehesjoki A.-E. Characterization of the cystatin B gene promoter harboring the dodecamer repeat expanded in progressive myoclonus epilepsy, EPM1. Gene. 242:2000;65-73.
10. Rinne R., Saukko P., Järvinen M., Lehesjoki A.-E. Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy. Ann. Med. 34:2002;380-385.
11. Järvinen M., Rinne A. Human spleen cysteine proteinase inhibitor: purification, fractionation into isoelectric variants and some properties of the variants. Biochim. Biophys. Acta. 708:1982;210-217.
12. Ritonja A., Machleidt W., Barrett A.J. Amino acid sequence of the intracellular cysteine proteinase inhibitor cystatin B from human liver. Biochem. Biophys. Res. Commun. 131:1985;1187-1192.
13. Turk V., Bode W. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 285:1991;213-219.
14. Pennacchio L.A., Bouley D.M., Higgins K.M., Scott M.P., Noebels J.L., Myers R.M. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat. Genet. 20:1998;251-258.
15. Shannon P., Pennacchio L.A., Houseweart M.K., Minassian B.A., Myers R.M. Neuropathological changes in a mouse model of progressive myoclonus epilepsy: cystatin B deficiency and Unverricht-Lundborg disease. J. Neuropathol. Exp. Neurol. 61:2002;1085-1091.
16. Lieuallen K., Pennacchio L.A., Park M., Myers R.M., Lennon G.G. Cystatin B-deficient mice have increased expression of apoptosis and glial activation genes. Hum. Mol. Genet. 10:2001;1867-1871.
17. Brännvall K., Korhonen L., Lindholm D. Oestrogen-receptor dependent regulation of neural stem cell proliferation and differentiation. Mol. Cell Neurosci. 21:2002;512-520.
18. Korhonen L., Brännvall K., Skoglösa Y., Lindholm D. The tumor suppressor gene BRCA-1 is expressed by embryonic and adult neural stem cells and is involved in stem cell proliferation. J. Neurosci. Res. 71:2003;769-776.
19. Johansson C.B., Momma S., Clarke D.L., Risling M., Lendahl U., Frisén J. Identification of a neural stem cell in the adult mammalian central nervous system. Cell. 96:1999;25-34.
20. Korhonen L., Belluardo N., Lindholm D. Regulation of X-chromosome linked inhibitor of apoptosis protein in kainic acid induced neuronal death in the rat hippocampus. Mol. Cell Neurosci. 17:2001;364-372.
21. Lindholm D., Castren E., Kiefer R., Zafra F., Thoenen H. Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J. Cell Biol. 117:1992;395-400.
22. Febbraio M., Silverstein R.L. Identification and characterization of LAMP-1 as an activation-dependent platelet surface glycoprotein. J. Biol. Chem. 265:1990;18531-18537.
23. Riccio M., Di Giaimo R., Pianetti S., Palmieri P.P., Melli M., Santi S. Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1). Exp. Cell Res. 262:2001;84-94.